arrow
E

Emily L. Jocoy

The Jackson Laboratory
H指数:4
被引数:48

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting Pediatric Glioblastomas by Combining OLIG2 Inhibitor CT-179 with Fractionated Radiation in a Panel of Patient-Derived Orthotopic Xenograft Mouse Models

在一组患者来源的原位异种移植小鼠模型中,通过将OLIG2抑制剂CT-179与分次放射相结合来靶向小儿胶质母细胞瘤

2026-02-050
OAAI
Adaptive evolution of drug responses to monotherapy ONC201 in PDOX models of pediatric brain tumors

ONC201单药疗法在儿童脑肿瘤PDOX模型中的药物反应适应性进化

2025-11-010
OAAI
The CD123 antibody-drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemia

CD123抗体药物偶联物pivekimab sunirine在儿童急性淋巴细胞白血病临床前模型中表现出显著的活性。

2025-01-171
OAAI
The novel ATR inhibitor elimusertib is efficacious as monotherapy and in combination with radiation in pdox models of pediatric high-grade glioma

新型ATR抑制剂elimusertib在小儿高级别神经胶质瘤的pdox模型中作为单药治疗和与放射联合治疗有效

2024-10-010
PRE
In vivo efficacy of anti-B7-H3 antibody-drug conjugate (ADC) ifinatamab deruxtecan (I-DXd; DS-7300): An update from the Pediatric Preclinical In Vivo Testing (PIVOT) Program
2024-04-051
PRE
A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non-Small Cell Lung Cancer
2022-09-0711
OAAI